Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NUP50 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DSN1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SLC1A4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DPYSL3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PID1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
UNG - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
H2AFY - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GLUD1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CAPRIN2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DYRK1A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PHF2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RFTN1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NAP1L4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
BTBD3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CST1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors
ID4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SEPHS1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LTBP4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CDKN2A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PNRC2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on